Eisai Korea announced on October 7th that it has signed a memorandum of understanding (MOU) with the Korean Dementia Association to utilize and manage 'JOY-ALZ,' a registry program for long-term follow-up survey platform of Alzheimer's disease prognosis.

The MOU aims to advance Alzheimer's disease treatment and to establish safe Alzheimer's disease treatment settings in South Korea.

According to the MOU, both companies will collaborate on establishing and running JOY-ALZ, thereby securing high-quality data on Alzheimer's disease patients. Based on this platform, they will establish and provide safe and optimized treatment settings for Alzheimer's disease patients in South Korea.